| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 07/20/2010 | CA2366694C Process for the preparation of cyclo (asp-dphe-nmeval-arg-gly) |
| 07/15/2010 | WO2010080836A2 Antibacterial and antifungal peptides |
| 07/15/2010 | WO2010079511A2 Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof |
| 07/15/2010 | WO2010079156A1 Non-invasive tools for detecting vulnerable atherosclerotic plaques |
| 07/15/2010 | WO2010079063A2 Modulators of the cx3cr1 receptor and therapeutic uses thereof |
| 07/15/2010 | WO2010053545A3 Apj receptor compounds |
| 07/15/2010 | WO2010035107A9 Peptides and compositions for prevention of cell adhesion and methods of using same |
| 07/15/2010 | WO2010033879A3 Inhibiting interaction between hif-1a and p300/cbp with hydrogen bond surrogate-based helices |
| 07/15/2010 | US20100179304 Somatostatin-Dopamine Chimeric analogs |
| 07/15/2010 | US20100179093 Neoropeptide-2-Receptor (Y-2R) Agonists |
| 07/15/2010 | US20100178324 Composition and method for the treatment of diseases affected by apoptosis |
| 07/15/2010 | CA2749047A1 Non-invasive tools for detecting vulnerable atherosclerotic plaques |
| 07/15/2010 | CA2748449A1 Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof |
| 07/15/2010 | CA2746976A1 Modulators of the cx3cr1 receptor and therapeutic uses thereof |
| 07/14/2010 | EP2206787A2 Peptide-enhanced transfections |
| 07/14/2010 | EP2206726A1 Non-invasive tools for detecting vulnerable atherosclerotic plaques |
| 07/14/2010 | EP2206721A1 Neuromedin u derivative |
| 07/14/2010 | EP1079859B1 Bifunctional molecules and therapies based thereon |
| 07/14/2010 | CN1865279B Solid phase polypeptide synthesis preparation method for thymopoietin pentapeptide |
| 07/14/2010 | CN101775429A Whey protein antioxidant peptides, preparation method thereof and application thereof |
| 07/14/2010 | CN101775067A New synthesized antibacterial peptide as well as preparation method and application thereof |
| 07/14/2010 | CN101255190B Use of human midkine protein blocking peptide in preparation of antitumor medicament |
| 07/13/2010 | US7754853 Tumor necrosis factors (TNF); site-directed mutagenesis, genetic deletions; monoclonal antibodies with decreased immunogenicity and lymphocyte epitopes; major histocompatibility complex binding ligands; for treatment of rheumatoid arthritis and Crohn's disease |
| 07/13/2010 | US7754690 Method of using retro inverso peptides derived from leukemia inhibitory factor |
| 07/13/2010 | US7754688 Methods of using retro-inverso peptides derived from interleukin-6 |
| 07/13/2010 | CA2347713C Contulakin-g, analogs thereof and uses therefor |
| 07/13/2010 | CA2271449C Diagnosis of feline immunodeficiency virus infection using env/gag polypeptide markers |
| 07/13/2010 | CA2262893C Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins |
| 07/08/2010 | WO2010077154A1 A method of producing a novel opioid peptide |
| 07/08/2010 | WO2010076329A1 Derivatives of cyclosporin a |
| 07/08/2010 | WO2010075986A1 Nitroprotein biomarkers for copd |
| 07/08/2010 | WO2010075604A1 Synthetic peptides, methods and kits for diagnosing autoimmune diseases |
| 07/08/2010 | WO2010033868A3 Ligand-specific non-antibody compounds that inhibit cr2 activation and methods of use thereof |
| 07/08/2010 | US20100173851 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 07/08/2010 | US20100173850 Improved Peptide Composition |
| 07/08/2010 | US20100173849 Neo-tryptophan |
| 07/08/2010 | US20100173848 Methods of inhibiting chemokine binding to chemokines receptors |
| 07/08/2010 | US20100173847 Tfpi inhibitors and methods of use |
| 07/08/2010 | US20100173838 Novel process for the preparation of cyclosporin derivatives |
| 07/08/2010 | US20100173836 Novel macrocycles |
| 07/08/2010 | US20100173835 Peptides for Treatment of Obesity |
| 07/08/2010 | US20100173834 Cyclic peptide melanocortin receptor ligands |
| 07/08/2010 | US20100173352 Method for preparing cells for engraftment |
| 07/08/2010 | US20100172938 Modified bacterial surface layer proteins |
| 07/08/2010 | US20100172930 Transfection complexes |
| 07/08/2010 | US20100172925 Hla-a2-restricted t-cell epitopes of the respiratory syncytial virus fusion protein as peptide-based vaccines |
| 07/08/2010 | US20100172864 Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
| 07/08/2010 | US20100172837 MN Gene and Protein |
| 07/08/2010 | CA2748389A1 Derivatives of cyclosporin a |
| 07/07/2010 | EP2204383A1 Processes for preparing eptifibatide and pertinent intermediate compounds |
| 07/07/2010 | EP2204379A1 Polypeptide compound |
| 07/07/2010 | EP2204378A1 A inhibiting agent for inhibition of angiogenesis, a method for preparing the agent, a method for modifying the agent and its use for manufacturing a medicament for treating tumor |
| 07/07/2010 | EP2204187A1 Human flu vaccine containing four influenza peptides |
| 07/07/2010 | EP2204181A2 Protease inhibitors |
| 07/07/2010 | EP1545595B1 Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains |
| 07/07/2010 | EP1499888B1 Conformationally constrained peptides that bind the orl-1 receptor |
| 07/07/2010 | EP0979284B2 Reagents for vaccination which generate a cd8 t cell immune response |
| 07/07/2010 | CN101772513A Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 07/07/2010 | CN101768591A Translation adjusting element and application thereof |
| 07/07/2010 | CN101768210A Tumor targeting polypeptide and preparation method thereof |
| 07/07/2010 | CN101235081B Method for preparing oxytocin |
| 07/07/2010 | CN101066990B Antitumor CTL epitope peptide possessing population broad spectrum property |
| 07/06/2010 | US7750136 Using ribosome-inactivating protein (RIP)/cytotoxin fusion to target and destroy tumor cells |
| 07/06/2010 | US7750121 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents |
| 07/06/2010 | US7750115 Epithelial cell growth promoter |
| 07/06/2010 | US7749725 Monitoring sensitivity of humans to sodium; obtain fluid sample, measure concentration og angiotensin enzyme in sample, evaluate for sensitivity to sodium |
| 07/06/2010 | US7749721 Immuno enzymatic quantification method for cholesterol ester transferring protein (CETP) |
| 07/06/2010 | US7749719 bioassay to detect diagnosis of skin cancer; isolated host cell transfected with the recombinant expression vector encoding an immunogenic protein; immunogen or vaccine for cancer prevention and treatment; immunotherapy |
| 07/06/2010 | US7749502 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with Porphyromonas gingivalis |
| 07/01/2010 | WO2010075535A1 Neurotrophins and uses thereof |
| 07/01/2010 | WO2010075416A1 Antibiotic compositions for the treatment of gram negative infections |
| 07/01/2010 | WO2010075215A1 Novel antibacterial agents for the treatment of gram positive infections |
| 07/01/2010 | WO2010074433A2 Novel bacteriophage and antibacterial composition comprising same |
| 07/01/2010 | WO2010073551A1 C1orf59 peptides and vaccines including the same |
| 07/01/2010 | WO2010072927A1 Peptides derived from hmg-coa reductase and cosmetic and/or pharmaceutical composition containing same |
| 07/01/2010 | WO2010072926A1 Hmg-coa reductase derived peptide and cosmetic or pharmaceutical composition containing same |
| 07/01/2010 | WO2010072843A2 Use of a peptide derived from er-alpha for restoring sensitivity to antiestrogenic compounds in breast tumour cells |
| 07/01/2010 | WO2010039461A3 Methods for synthesis and uses of inhibitors of ghrelin o-acyltransferase as potential therapeutic agents for obesity and diabetes |
| 07/01/2010 | WO2010024927A3 Treatment of amyloidoses using myelin basic protein and fragments thereof |
| 07/01/2010 | US20100168383 Skin or Hair Binding Peptides |
| 07/01/2010 | US20100168382 Neuroplastin derived peptides |
| 07/01/2010 | US20100168381 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 07/01/2010 | US20100168037 Peptides comprising aromatic d-amino acids and methods of use |
| 07/01/2010 | US20100168036 Growth factor |
| 07/01/2010 | US20100168034 Peptide having cell membrane penetrating activity |
| 07/01/2010 | US20100168033 Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders |
| 07/01/2010 | US20100168032 Smart Pro-Drugs of Serine Protease Inhibitors |
| 07/01/2010 | US20100168031 Lat peptides and their use in assays for identifying immunosuppressants |
| 07/01/2010 | US20100168015 Peptides with capacity for binding with interleukine 10 (il-10) |
| 07/01/2010 | US20100167996 3-Ether and 3-Thioether Substituted Cyclosporin Derivatives For the Treatment and Prevention of Hepatitis C Infection |
| 07/01/2010 | US20100167348 Peptide capable of binding to immunoglobulin |
| 07/01/2010 | US20100166791 Circovirus sequences associated with piglet weight loss disease (pwd) |
| 07/01/2010 | US20100166789 Proteins for use in diagnosing and treating infection and disease |
| 07/01/2010 | US20100166788 Immunogens from uropathogenic escherichia coli |
| 07/01/2010 | US20100166782 Clip inhibitors and methods of modulating immune function |
| 07/01/2010 | US20100166759 Metallothionein-Derived Peptide Fragments |
| 07/01/2010 | US20100166748 C5 Antigens and Uses Thereof |
| 07/01/2010 | US20100166738 Compositions and methods for wt1 specific immunotherapy |
| 07/01/2010 | US20100166654 Single-Drug Multi-Ligand Conjugates for Targeted Drug Delivery |
| 07/01/2010 | CA2747995A1 Antibiotic compositions for the treatment of gram negative infections |